News

In the lean years since the post-genomics bust, venture funding has been hard to come by for Europe’s biotech start-ups. Now they have polished up their business models, and valuations are low, attracting investors back in.

The Lisbon strategy aim of making Europe the leading knowledge-based economy remains a far-off aspiration. Now the UK wants a fresh approach to the single market to move things forward.

Under pressure to demonstrate economic returns on research spending, the UK’s research councils are going to make academics think commercial and to cosy up to industry.